This article needs to be updated. The reason given is: no files for 2006 are listed at the cited source, but files for 2013 are there; NLM releases this information annually. Please help update this article to reflect recent events or newly available information. (February 2020)

The following is a partial list of the "C" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM).

This list continues the information at List of MeSH codes (C03). Codes following these are found at List of MeSH codes (C05). For other MeSH codes, see List of MeSH codes.

The source for this content is the set of 2006 MeSH Trees from the NLM.

MeSH  C04 – neoplasms

MeSH  C04.182 – cysts

MeSH  C04.182.044 – arachnoid cysts

MeSH  C04.182.089 – bone cysts

• MeSH  C04.182.089.265 – bone cysts, aneurysmal
• MeSH  C04.182.089.530 – jaw cysts
• MeSH  C04.182.089.530.660 – nonodontogenic cysts
• MeSH  C04.182.089.530.690 – odontogenic cysts
• MeSH  C04.182.089.530.690.150 – basal cell nevus syndrome
• MeSH  C04.182.089.530.690.310 – dentigerous cyst
• MeSH  C04.182.089.530.690.605 – odontogenic cyst, calcifying
• MeSH  C04.182.089.530.690.790 – periodontal cyst
• MeSH  C04.182.089.530.690.790.820 – radicular cyst

MeSH  C04.182.117 – branchioma

MeSH  C04.182.156 – breast cyst

MeSH  C04.182.195 – bronchogenic cyst

MeSH  C04.182.197 – chalazion

MeSH  C04.182.198 – choledochal cyst

MeSH  C04.182.201 – dermoid cyst

MeSH  C04.182.254 – epidermal cyst

MeSH  C04.182.281 – esophageal cyst

MeSH  C04.182.300 – follicular cyst

MeSH  C04.182.347 – ganglion cysts

MeSH  C04.182.430 – lymphocele

MeSH  C04.182.444 – mediastinal cyst

MeSH  C04.182.473 – mesenteric cyst

MeSH  C04.182.511 – mucocele

MeSH  C04.182.612 – ovarian cysts

• MeSH  C04.182.612.765 – polycystic ovary syndrome

MeSH  C04.182.640 – pancreatic cyst

• MeSH  C04.182.640.692 – pancreatic pseudocyst

MeSH  C04.182.668 – parovarian cyst

MeSH  C04.182.710 – pilonidal sinus

MeSH  C04.182.766 – ranula

MeSH  C04.182.867 – synovial cyst

• MeSH  C04.182.867.500 – popliteal cyst

MeSH  C04.182.902 – thyroglossal cyst

MeSH  C04.182.946 – urachal cyst

MeSH  C04.445 – hamartoma

MeSH  C04.445.435 – hamartoma syndrome, multiple

MeSH  C04.445.620 – proteus syndrome

MeSH  C04.445.810 – tuberous sclerosis

MeSH  C04.557 – neoplasms by histologic type

MeSH  C04.557.227 – histiocytic disorders, malignant

• MeSH  C04.557.227.400 – histiocytosis, malignant
• MeSH  C04.557.227.500 – leukemia, monocytic, acute
• MeSH  C04.557.227.510 – lymphoma, large-cell
• MeSH  C04.557.227.510.465 – lymphoma, large-cell, ki-1

MeSH  C04.557.337 – leukemia

• MeSH  C04.557.337.100 – enzootic bovine leukosis
• MeSH  C04.557.337.372 – leukemia, experimental
• MeSH  C04.557.337.372.216 – avian leukosis
• MeSH  C04.557.337.372.594 – leukemia L1210
• MeSH  C04.557.337.372.602 – leukemia L5178
• MeSH  C04.557.337.372.782 – leukemia p388
• MeSH  C04.557.337.385 – leukemia, feline
• MeSH  C04.557.337.415 – leukemia, hairy cell
• MeSH  C04.557.337.415.700 – leukemia, t-cell, htlv-ii-associated
• MeSH  C04.557.337.428 – leukemia, lymphocytic
• MeSH  C04.557.337.428.500 – leukemia, b-cell
• MeSH  C04.557.337.428.500.100 – leukemia, b-cell, acute
• MeSH  C04.557.337.428.500.125 – leukemia, B-Cell, chronic
• MeSH  C04.557.337.428.500.500 – leukemia, pre-b-cell
• MeSH  C04.557.337.428.511 – leukemia, lymphocytic, acute
• MeSH  C04.557.337.428.511.100 – leukemia, b-cell, acute
• MeSH  C04.557.337.428.511.225 – leukemia, calla-positive
• MeSH  C04.557.337.428.511.400 – leukemia, lymphocytic, acute, L1
• MeSH  C04.557.337.428.511.410 – leukemia, lymphocytic, acute, L2
• MeSH  C04.557.337.428.511.500 – leukemia, mixed-cell
• MeSH  C04.557.337.428.511.550 – leukemia, null-cell
• MeSH  C04.557.337.428.511.800 – leukemia, t-cell, acute
• MeSH  C04.557.337.428.511.800.300 – leukemia-lymphoma, t-cell, acute, htlv-i-associated
• MeSH  C04.557.337.428.550 – leukemia, lymphocytic, chronic
• MeSH  C04.557.337.428.550.250 – leukemia, B-Cell, chronic
• MeSH  C04.557.337.428.550.675 – leukemia, prolymphocytic
• MeSH  C04.557.337.428.550.800 – leukemia, T-Cell, chronic
• MeSH  C04.557.337.428.580 – leukemia, t-cell
• MeSH  C04.557.337.428.580.100 – leukemia, t-cell, acute
• MeSH  C04.557.337.428.580.100.300 – leukemia-lymphoma, t-cell, acute, htlv-i-associated
• MeSH  C04.557.337.428.580.125 – leukemia, T-Cell, chronic
• MeSH  C04.557.337.428.580.400 – leukemia, t-cell, htlv-ii-associated
• MeSH  C04.557.337.440 – leukemia, mast-cell
• MeSH  C04.557.337.539 – leukemia, myeloid
• MeSH  C04.557.337.539.250 – leukemia, myeloid, chronic
• MeSH  C04.557.337.539.250.200 – blast crisis
• MeSH  C04.557.337.539.250.275 – leukemia, monocytic, chronic
• MeSH  C04.557.337.539.250.300 – leukemia, myeloid, aggressive-phase
• MeSH  C04.557.337.539.250.400 – leukemia, myeloid, chronic-phase
• MeSH  C04.557.337.539.250.500 – leukemia, myelomonocytic, chronic
• MeSH  C04.557.337.539.250.550 – leukemia, neutrophilic, chronic
• MeSH  C04.557.337.539.500 – leukemia, myeloid, philadelphia-negative
• MeSH  C04.557.337.539.510 – leukemia, myeloid, philadelphia-positive
• MeSH  C04.557.337.539.520 – leukemia, myelomonocytic, acute
• MeSH  C04.557.337.539.550 – leukemia, nonlymphocytic, acute
• MeSH  C04.557.337.539.550.125 – leukemia, basophilic, acute
• MeSH  C04.557.337.539.550.300 – leukemia, eosinophilic, acute
• MeSH  C04.557.337.539.550.325 – leukemia, erythroblastic, acute
• MeSH  C04.557.337.539.550.440 – leukemia, mast-cell
• MeSH  C04.557.337.539.550.450 – leukemia, megakaryocytic, acute
• MeSH  C04.557.337.539.550.484 – leukemia, monocytic, acute
• MeSH  C04.557.337.539.550.512 – leukemia, myelocytic, acute
• MeSH  C04.557.337.539.550.700 – leukemia, promyelocytic, acute
• MeSH  C04.557.337.539.775 – sarcoma, granulocytic
• MeSH  C04.557.337.595 – leukemia, plasmacytic
• MeSH  C04.557.337.650 – leukemia, radiation-induced
• MeSH  C04.557.337.706 – leukemia, subleukemic

MeSH  C04.557.375 – lymphatic vessel tumors

• MeSH  C04.557.375.450 – lymphangioma
• MeSH  C04.557.375.450.450 – lymphangioma, cystic
• MeSH  C04.557.375.460 – lymphangiomyoma
• MeSH  C04.557.375.460.465 – lymphangioleiomyomatosis
• MeSH  C04.557.375.480 – lymphangiosarcoma

MeSH  C04.557.386 – lymphoma

• MeSH  C04.557.386.345 – histiocytosis, malignant
• MeSH  C04.557.386.355 – hodgkin disease
• MeSH  C04.557.386.390 – immunoproliferative small intestinal disease
• MeSH  C04.557.386.480 – lymphoma, non-hodgkin
• MeSH  C04.557.386.480.150 – B-cell lymphoma
• MeSH  C04.557.386.480.150.165 – burkitt lymphoma
• MeSH  C04.557.386.480.150.450 – lymphoma, aids-related
• MeSH  C04.557.386.480.150.570 – lymphoma, mucosa-associated lymphoid tissue
• MeSH  C04.557.386.480.150.700 – lymphoma, small-cell
• MeSH  C04.557.386.480.300 – lymphoma, diffuse
• MeSH  C04.557.386.480.300.300 – lymphoma, large-cell, diffuse
• MeSH  C04.557.386.480.300.450 – lymphoma, large-cell, immunoblastic
• MeSH  C04.557.386.480.300.475 – lymphoma, lymphoblastic
• MeSH  C04.557.386.480.300.500 – lymphoma, mixed-cell, diffuse
• MeSH  C04.557.386.480.300.725 – lymphoma, small cleaved-cell, diffuse
• MeSH  C04.557.386.480.300.725.500 – lymphoma, mantle-cell
• MeSH  C04.557.386.480.300.750 – lymphoma, small lymphocytic
• MeSH  C04.557.386.480.300.775 – lymphoma, small noncleaved-cell
• MeSH  C04.557.386.480.350 – lymphoma, follicular
• MeSH  C04.557.386.480.350.350 – lymphoma, large-cell, follicular
• MeSH  C04.557.386.480.350.525 – lymphoma, mixed-cell, follicular
• MeSH  C04.557.386.480.350.750 – lymphoma, small cleaved-cell, follicular
• MeSH  C04.557.386.480.425 – lymphoma, high-grade
• MeSH  C04.557.386.480.425.450 – lymphoma, large-cell, immunoblastic
• MeSH  C04.557.386.480.425.475 – lymphoma, lymphoblastic
• MeSH  C04.557.386.480.425.775 – lymphoma, small noncleaved-cell
• MeSH  C04.557.386.480.425.775.165 – burkitt lymphoma
• MeSH  C04.557.386.480.450 – lymphoma, intermediate-grade
• MeSH  C04.557.386.480.450.300 – lymphoma, large-cell, diffuse
• MeSH  C04.557.386.480.450.350 – lymphoma, large-cell, follicular
• MeSH  C04.557.386.480.450.500 – lymphoma, mixed-cell, diffuse
• MeSH  C04.557.386.480.450.725 – lymphoma, small cleaved-cell, diffuse
• MeSH  C04.557.386.480.450.725.500 – lymphoma, mantle-cell
• MeSH  C04.557.386.480.475 – lymphoma, large-cell
• MeSH  C04.557.386.480.475.300 – lymphoma, large-cell, diffuse
• MeSH  C04.557.386.480.475.350 – lymphoma, large-cell, follicular
• MeSH  C04.557.386.480.475.450 – lymphoma, large-cell, immunoblastic
• MeSH  C04.557.386.480.475.465 – lymphoma, large-cell, ki-1
• MeSH  C04.557.386.480.475.475 – lymphoma, lymphoblastic
• MeSH  C04.557.386.480.500 – lymphoma, low-grade
• MeSH  C04.557.386.480.500.525 – lymphoma, mixed-cell, follicular
• MeSH  C04.557.386.480.500.570 – lymphoma, mucosa-associated lymphoid tissue
• MeSH  C04.557.386.480.500.750 – lymphoma, small cleaved-cell, follicular
• MeSH  C04.557.386.480.500.770 – lymphoma, small lymphocytic
• MeSH  C04.557.386.480.550 – lymphoma, mixed-cell
• MeSH  C04.557.386.480.550.500 – lymphoma, mixed-cell, diffuse
• MeSH  C04.557.386.480.550.525 – lymphoma, mixed-cell, follicular
• MeSH  C04.557.386.480.700 – lymphoma, small-cell
• MeSH  C04.557.386.480.700.725 – lymphoma, small cleaved-cell, diffuse
• MeSH  C04.557.386.480.700.725.500 – lymphoma, mantle-cell
• MeSH  C04.557.386.480.700.730 – lymphoma, small cleaved-cell, follicular
• MeSH  C04.557.386.480.700.750 – lymphoma, small lymphocytic
• MeSH  C04.557.386.480.700.775 – lymphoma, small noncleaved-cell
• MeSH  C04.557.386.480.750 – lymphoma, t-cell
• MeSH  C04.557.386.480.750.475 – lymphoma, lymphoblastic
• MeSH  C04.557.386.480.750.800 – lymphoma, t-cell, cutaneous
• MeSH  C04.557.386.480.750.800.465 – lymphoma, large-cell, ki-1
• MeSH  C04.557.386.480.750.800.550 – mycosis fungoides
• MeSH  C04.557.386.480.750.800.775 – sezary syndrome
• MeSH  C04.557.386.480.750.825 – lymphoma, t-cell, peripheral
• MeSH  C04.557.386.480.875 – lymphoma, undifferentiated
• MeSH  C04.557.386.480.875.300 – lymphoma, large-cell, diffuse
• MeSH  C04.557.386.480.875.775 – lymphoma, small noncleaved-cell
• MeSH  C04.557.386.480.875.775.165 – burkitt lymphoma
• MeSH  C04.557.386.720 – plasmacytoma
• MeSH  C04.557.386.720.550 – multiple myeloma
• MeSH  C04.557.386.802 – reticuloendotheliosis
• MeSH  C04.557.386.802.750 – mast-cell sarcoma

MeSH  C04.557.435 – neoplasms, complex and mixed

• MeSH  C04.557.435.075 – adenolymphoma
• MeSH  C04.557.435.090 – adenoma, pleomorphic
• MeSH  C04.557.435.110 – adenomyoma
• MeSH  C04.557.435.135 – adenosarcoma
• MeSH  C04.557.435.250 – carcinoma, adenosquamous
• MeSH  C04.557.435.290 – carcinosarcoma
• MeSH  C04.557.435.290.210 – carcinoma 256, walker
• MeSH  C04.557.435.380 – hepatoblastoma
• MeSH  C04.557.435.500 – mesenchymoma
• MeSH  C04.557.435.525 – mixed tumor, malignant
• MeSH  C04.557.435.530 – mixed tumor, mesodermal
• MeSH  C04.557.435.540 – mixed tumor, Müllerian
• MeSH  C04.557.435.585 – myoepithelioma
• MeSH  C04.557.435.595 – wilms tumor
• MeSH  C04.557.435.595.220 – denys-drash syndrome
• MeSH  C04.557.435.595.950 – wagr syndrome
• MeSH  C04.557.435.600 – nephroma, mesoblastic
• MeSH  C04.557.435.675 – pulmonary blastoma
• MeSH  C04.557.435.710 – rhabdoid tumor
• MeSH  C04.557.435.775 – sarcoma, endometrial stromal
• MeSH  C04.557.435.850 – thymoma

MeSH  C04.557.450 – neoplasms, connective and soft tissue

• MeSH  C04.557.450.550 – neoplasms, adipose tissue
• MeSH  C04.557.450.550.100 – angiolipoma
• MeSH  C04.557.450.550.125 – angiomyolipoma
• MeSH  C04.557.450.550.400 – lipoma
• MeSH  C04.557.450.550.420 – liposarcoma
• MeSH  C04.557.450.550.420.425 – liposarcoma, myxoid
• MeSH  C04.557.450.550.710 – myelolipoma
• MeSH  C04.557.450.565 – neoplasms, connective tissue
• MeSH  C04.557.450.565.250 – chondroblastoma
• MeSH  C04.557.450.565.265 – chondroma
• MeSH  C04.557.450.565.265.270 – chondromatosis
• MeSH  C04.557.450.565.280 – chondrosarcoma
• MeSH  C04.557.450.565.280.280 – chondrosarcoma, mesenchymal
• MeSH  C04.557.450.565.380 – giant cell tumors
• MeSH  C04.557.450.565.380.380 – giant cell tumor of bone
• MeSH  C04.557.450.565.465 – mastocytosis
• MeSH  C04.557.450.565.465.249 – mastocytoma
• MeSH  C04.557.450.565.465.500 – mastocytosis, cutaneous
• MeSH  C04.557.450.565.465.500.500 – urticaria pigmentosa
• MeSH  C04.557.450.565.465.750 – mastocytosis, systemic
• MeSH  C04.557.450.565.465.750.500 – leukemia, mast-cell
• MeSH  C04.557.450.565.465.875 – mast-cell sarcoma
• MeSH  C04.557.450.565.540 – myofibroma
• MeSH  C04.557.450.565.550 – myxoma
• MeSH  C04.557.450.565.550.625 – neurothekeoma
• MeSH  C04.557.450.565.560 – myxosarcoma
• MeSH  C04.557.450.565.575 – neoplasms, bone tissue
• MeSH  C04.557.450.565.575.400 – fibroma, ossifying
• MeSH  C04.557.450.565.575.420 – giant cell tumor of bone
• MeSH  C04.557.450.565.575.600 – osteoblastoma
• MeSH  C04.557.450.565.575.610 – osteochondroma
• MeSH  C04.557.450.565.575.610.615 – osteochondromatosis
• MeSH  C04.557.450.565.575.610.615.325 – exostoses, multiple hereditary
• MeSH  C04.557.450.565.575.625 – osteoma
• MeSH  C04.557.450.565.575.625.625 – osteoma, osteoid
• MeSH  C04.557.450.565.575.650 – osteosarcoma
• MeSH  C04.557.450.565.575.650.655 – osteosarcoma, juxtacortical
• MeSH  C04.557.450.565.575.650.800 – sarcoma, Ewing's
• MeSH  C04.557.450.565.590 – neoplasms, fibrous tissue
• MeSH  C04.557.450.565.590.340 – fibroma
• MeSH  C04.557.450.565.590.340.345 – fibroma, desmoplastic
• MeSH  C04.557.450.565.590.340.360 – fibroma, ossifying
• MeSH  C04.557.450.565.590.340.400 – fibromatosis, abdominal
• MeSH  C04.557.450.565.590.340.410 – fibromatosis, aggressive
• MeSH  C04.557.450.565.590.350 – fibrosarcoma
• MeSH  C04.557.450.565.590.350.320 – dermatofibrosarcoma
• MeSH  C04.557.450.565.590.350.590 – neurofibrosarcoma
• MeSH  C04.557.450.565.590.425 – histiocytoma
• MeSH  C04.557.450.565.590.425.350 – histiocytoma, benign fibrous
• MeSH  C04.557.450.565.590.425.360 – histiocytoma, malignant fibrous
• MeSH  C04.557.450.565.590.550 – myofibromatosis
• MeSH  C04.557.450.565.590.595 – neoplasms, fibroepithelial
• MeSH  C04.557.450.565.590.595.050 – adenofibroma
• MeSH  C04.557.450.565.590.595.150 – brenner tumor
• MeSH  C04.557.450.565.590.595.350 – fibroadenoma
• MeSH  C04.557.450.565.800 – sarcoma, clear cell
• MeSH  C04.557.450.565.825 – sarcoma, small cell
• MeSH  C04.557.450.565.835 – sarcoma, synovial
• MeSH  C04.557.450.590 – neoplasms, muscle tissue
• MeSH  C04.557.450.590.350 – granular cell tumor
• MeSH  C04.557.450.590.450 – leiomyoma
• MeSH  C04.557.450.590.450.125 – angiomyoma
• MeSH  C04.557.450.590.450.455 – leiomyoma, epithelioid
• MeSH  C04.557.450.590.450.465 – leiomyomatosis
• MeSH  C04.557.450.590.455 – leiomyosarcoma
• MeSH  C04.557.450.590.540 – myoma
• MeSH  C04.557.450.590.540.700 – rhabdomyoma
• MeSH  C04.557.450.590.550 – myosarcoma
• MeSH  C04.557.450.590.550.660 – rhabdomyosarcoma
• MeSH  C04.557.450.590.550.660.665 – rhabdomyosarcoma, alveolar
• MeSH  C04.557.450.590.550.660.675 – rhabdomyosarcoma, embryonal
• MeSH  C04.557.450.590.775 – sarcoma, alveolar soft part
• MeSH  C04.557.450.590.800 – smooth muscle tumor
• MeSH  C04.557.450.795 – sarcoma
• MeSH  C04.557.450.795.135 – adenosarcoma
• MeSH  C04.557.450.795.290 – carcinosarcoma
• MeSH  C04.557.450.795.290.210 – carcinoma 256, walker
• MeSH  C04.557.450.795.300 – chondrosarcoma
• MeSH  C04.557.450.795.300.280 – chondrosarcoma, mesenchymal
• MeSH  C04.557.450.795.350 – fibrosarcoma
• MeSH  C04.557.450.795.350.320 – dermatofibrosarcoma
• MeSH  C04.557.450.795.350.590 – neurofibrosarcoma
• MeSH  C04.557.450.795.390 – hemangiosarcoma
• MeSH  C04.557.450.795.400 – histiocytoma, malignant fibrous
• MeSH  C04.557.450.795.455 – leiomyosarcoma
• MeSH  C04.557.450.795.465 – liposarcoma
• MeSH  C04.557.450.795.465.425 – liposarcoma, myxoid
• MeSH  C04.557.450.795.480 – lymphangiosarcoma
• MeSH  C04.557.450.795.530 – mixed tumor, mesodermal
• MeSH  C04.557.450.795.550 – myosarcoma
• MeSH  C04.557.450.795.550.660 – rhabdomyosarcoma
• MeSH  C04.557.450.795.550.660.665 – rhabdomyosarcoma, alveolar
• MeSH  C04.557.450.795.550.660.675 – rhabdomyosarcoma, embryonal
• MeSH  C04.557.450.795.560 – myxosarcoma
• MeSH  C04.557.450.795.620 – osteosarcoma
• MeSH  C04.557.450.795.620.655 – osteosarcoma, juxtacortical
• MeSH  C04.557.450.795.620.800 – sarcoma, Ewing's
• MeSH  C04.557.450.795.650 – phyllodes tumor
• MeSH  C04.557.450.795.775 – sarcoma, alveolar soft part
• MeSH  C04.557.450.795.800 – sarcoma, clear cell
• MeSH  C04.557.450.795.820 – sarcoma, endometrial stromal
• MeSH  C04.557.450.795.830 – sarcoma, experimental
• MeSH  C04.557.450.795.830.760 – sarcoma 37
• MeSH  C04.557.450.795.830.780 – sarcoma 180
• MeSH  C04.557.450.795.830.800 – sarcoma, avian
• MeSH  C04.557.450.795.830.850 – sarcoma, yoshida
• MeSH  C04.557.450.795.840 – sarcoma, granulocytic
• MeSH  C04.557.450.795.850 – sarcoma, kaposi
• MeSH  C04.557.450.795.870 – sarcoma, small cell
• MeSH  C04.557.450.795.875 – sarcoma, synovial

MeSH  C04.557.465 – neoplasms, germ cell and embryonal

• MeSH  C04.557.465.200 – carcinoma, embryonal
• MeSH  C04.557.465.220 – chordoma
• MeSH  C04.557.465.280 – dermoid cyst
• MeSH  C04.557.465.330 – germinoma
• MeSH  C04.557.465.330.300 – dysgerminoma
• MeSH  C04.557.465.330.800 – seminoma
• MeSH  C04.557.465.420 – gonadoblastoma
• MeSH  C04.557.465.510 – mesonephroma
• MeSH  C04.557.465.510.350 – endodermal sinus tumor
• MeSH  C04.557.465.625 – neuroectodermal tumors
• MeSH  C04.557.465.625.200 – craniopharyngioma
• MeSH  C04.557.465.625.600 – neoplasms, neuroepithelial
• MeSH  C04.557.465.625.600.355 – ganglioneuroma
• MeSH  C04.557.465.625.600.380 – glioma
• MeSH  C04.557.465.625.600.380.080 – astrocytoma
• MeSH  C04.557.465.625.600.380.080.335 – glioblastoma
• MeSH  C04.557.465.625.600.380.080.667 – optic nerve glioma
• MeSH  C04.557.465.625.600.380.290 – ependymoma
• MeSH  C04.557.465.625.600.380.290.390 – glioma, subependymal
• MeSH  C04.557.465.625.600.380.350 – ganglioglioma
• MeSH  C04.557.465.625.600.380.400 – gliosarcoma
• MeSH  C04.557.465.625.600.380.515 – medulloblastoma
• MeSH  C04.557.465.625.600.380.590 – oligodendroglioma
• MeSH  C04.557.465.625.600.380.795 – optic nerve glioma
• MeSH  C04.557.465.625.600.580 – neurocytoma
• MeSH  C04.557.465.625.600.590 – neuroectodermal tumors, primitive
• MeSH  C04.557.465.625.600.590.500 – medulloblastoma
• MeSH  C04.557.465.625.600.590.650 – neuroectodermal tumors, primitive, peripheral
• MeSH  C04.557.465.625.600.590.650.550 – neuroblastoma
• MeSH  C04.557.465.625.600.590.650.550.150 – esthesioneuroblastoma, olfactory
• MeSH  C04.557.465.625.600.590.650.550.300 – ganglioneuroblastoma
• MeSH  C04.557.465.625.600.657 – pinealoma
• MeSH  C04.557.465.625.600.725 – retinoblastoma
• MeSH  C04.557.465.625.630 – neuroectodermal tumor, melanotic
• MeSH  C04.557.465.625.650 – neuroendocrine tumors
• MeSH  C04.557.465.625.650.025 – adenoma, acidophil
• MeSH  C04.557.465.625.650.075 – adenoma, basophil
• MeSH  C04.557.465.625.650.095 – adenoma, chromophobe
• MeSH  C04.557.465.625.650.135 – apudoma
• MeSH  C04.557.465.625.650.200 – carcinoid tumor
• MeSH  C04.557.465.625.650.200.500 – malignant carcinoid syndrome
• MeSH  C04.557.465.625.650.200.500.205 – carcinoid heart disease
• MeSH  C04.557.465.625.650.240 – carcinoma, neuroendocrine
• MeSH  C04.557.465.625.650.240.315 – carcinoma, medullary
• MeSH  C04.557.465.625.650.240.325 – carcinoma, merkel cell
• MeSH  C04.557.465.625.650.240.390 – carcinoma, small cell
• MeSH  C04.557.465.625.650.240.695 – somatostatinoma
• MeSH  C04.557.465.625.650.240.847 – vipoma
• MeSH  C04.557.465.625.650.510 – melanoma
• MeSH  C04.557.465.625.650.510.385 – hutchinson's melanotic freckle
• MeSH  C04.557.465.625.650.510.515 – melanoma, amelanotic
• MeSH  C04.557.465.625.650.510.525 – melanoma, experimental
• MeSH  C04.557.465.625.650.595 – neurilemmoma
• MeSH  C04.557.465.625.650.595.610 – neuroma, acoustic
• MeSH  C04.557.465.625.650.595.610.500 – neurofibromatosis 2
• MeSH  C04.557.465.625.650.700 – paraganglioma
• MeSH  C04.557.465.625.650.700.705 – paraganglioma, extra-adrenal
• MeSH  C04.557.465.625.650.700.705.220 – carotid body tumor
• MeSH  C04.557.465.625.650.700.705.340 – glomus jugulare tumor
• MeSH  C04.557.465.625.650.700.705.360 – glomus tympanicum tumor
• MeSH  C04.557.465.625.650.700.725 – pheochromocytoma
• MeSH  C04.557.465.900 – teratocarcinoma
• MeSH  C04.557.465.910 – teratoma
• MeSH  C04.557.465.910.850 – struma ovarii
• MeSH  C04.557.465.955 – trophoblastic neoplasms
• MeSH  C04.557.465.955.207 – choriocarcinoma
• MeSH  C04.557.465.955.207.750 – choriocarcinoma, non-gestational
• MeSH  C04.557.465.955.207.875 – trophoblastic tumor, placental site
• MeSH  C04.557.465.955.416 – gestational trophoblastic neoplasms
• MeSH  C04.557.465.955.416.202 – choriocarcinoma
• MeSH  C04.557.465.955.416.202.875 – trophoblastic tumor, placental site
• MeSH  C04.557.465.955.416.812 – hydatidiform mole
• MeSH  C04.557.465.955.416.812.500 – hydatidiform mole, invasive

MeSH  C04.557.470 – neoplasms, glandular and epithelial

• MeSH  C04.557.470.035 – adenoma
• MeSH  C04.557.470.035.012 – acth-secreting pituitary adenoma
• MeSH  C04.557.470.035.025 – adenoma, acidophil
• MeSH  C04.557.470.035.075 – adenoma, basophil
• MeSH  C04.557.470.035.085 – adenoma, bile duct
• MeSH  C04.557.470.035.095 – adenoma, chromophobe
• MeSH  C04.557.470.035.100 – adenoma, islet cell
• MeSH  C04.557.470.035.100.852 – insulinoma
• MeSH  C04.557.470.035.120 – adenoma, liver cell
• MeSH  C04.557.470.035.140 – adenoma, oxyphilic
• MeSH  C04.557.470.035.155 – adenoma, pleomorphic
• MeSH  C04.557.470.035.175 – adenoma, sweat gland
• MeSH  C04.557.470.035.175.125 – acrospiroma, eccrine
• MeSH  C04.557.470.035.175.375 – hidrocystoma
• MeSH  C04.557.470.035.175.800 – syringoma
• MeSH  C04.557.470.035.185 – adenoma, villous
• MeSH  C04.557.470.035.200 – adenomatoid tumor
• MeSH  C04.557.470.035.210 – adenomatosis, pulmonary
• MeSH  C04.557.470.035.215 – adenomatous polyps
• MeSH  C04.557.470.035.215.100 – adenomatous polyposis coli
• MeSH  C04.557.470.035.215.100.500 – gardner syndrome
• MeSH  C04.557.470.035.232 – adrenal rest tumor
• MeSH  C04.557.470.035.250 – apudoma
• MeSH  C04.557.470.035.320 – cystadenoma
• MeSH  C04.557.470.035.320.225 – cystadenoma, mucinous
• MeSH  C04.557.470.035.320.230 – cystadenoma, papillary
• MeSH  C04.557.470.035.320.240 – cystadenoma, serous
• MeSH  C04.557.470.035.415 – growth hormone-secreting pituitary adenoma
• MeSH  C04.557.470.035.510 – mesothelioma
• MeSH  C04.557.470.035.510.515 – mesothelioma, cystic
• MeSH  C04.557.470.035.625 – prolactinoma
• MeSH  C04.557.470.200 – carcinoma
• MeSH  C04.557.470.200.025 – adenocarcinoma
• MeSH  C04.557.470.200.025.030 – adenocarcinoma, bronchiolo-alveolar
• MeSH  C04.557.470.200.025.045 – adenocarcinoma, clear cell
• MeSH  C04.557.470.200.025.060 – adenocarcinoma, follicular
• MeSH  C04.557.470.200.025.060.225 – carcinoma, papillary, follicular
• MeSH  C04.557.470.200.025.075 – adenocarcinoma, mucinous
• MeSH  C04.557.470.200.025.085 – adenocarcinoma, papillary
• MeSH  C04.557.470.200.025.085.225 – carcinoma, papillary, follicular
• MeSH  C04.557.470.200.025.095 – adenocarcinoma, scirrhous
• MeSH  C04.557.470.200.025.095.410 – linitis plastica
• MeSH  C04.557.470.200.025.105 – adenocarcinoma, sebaceous
• MeSH  C04.557.470.200.025.152 – adrenocortical carcinoma
• MeSH  C04.557.470.200.025.200 – carcinoid tumor
• MeSH  C04.557.470.200.025.200.500 – malignant carcinoid syndrome
• MeSH  C04.557.470.200.025.200.500.205 – carcinoid heart disease
• MeSH  C04.557.470.200.025.215 – carcinoma, acinar cell
• MeSH  C04.557.470.200.025.220 – carcinoma, adenoid cystic
• MeSH  C04.557.470.200.025.232 – carcinoma, ductal
• MeSH  C04.557.470.200.025.232.500 – carcinoma, ductal, breast
• MeSH  C04.557.470.200.025.232.750 – carcinoma, pancreatic ductal
• MeSH  C04.557.470.200.025.240 – carcinoma, endometrioid
• MeSH  C04.557.470.200.025.255 – carcinoma, hepatocellular
• MeSH  C04.557.470.200.025.275 – carcinoma, intraductal, noninfiltrating
• MeSH  C04.557.470.200.025.275.625 – paget's disease, mammary
• MeSH  C04.557.470.200.025.290 – carcinoma, islet cell
• MeSH  C04.557.470.200.025.290.500 – gastrinoma
• MeSH  C04.557.470.200.025.290.750 – glucagonoma
• MeSH  C04.557.470.200.025.305 – carcinoma, lobular
• MeSH  C04.557.470.200.025.340 – carcinoma, mucoepidermoid
• MeSH  C04.557.470.200.025.370 – carcinoma, neuroendocrine
• MeSH  C04.557.470.200.025.370.315 – carcinoma, medullary
• MeSH  C04.557.470.200.025.370.325 – carcinoma, merkel cell
• MeSH  C04.557.470.200.025.370.390 – carcinoma, small cell
• MeSH  C04.557.470.200.025.370.695 – somatostatinoma
• MeSH  C04.557.470.200.025.370.847 – vipoma
• MeSH  C04.557.470.200.025.390 – carcinoma, renal cell
• MeSH  C04.557.470.200.025.415 – carcinoma, signet ring cell
• MeSH  C04.557.470.200.025.415.410 – krukenberg tumor
• MeSH  C04.557.470.200.025.420 – carcinoma, skin appendage
• MeSH  C04.557.470.200.025.450 – cholangiocarcinoma
• MeSH  C04.557.470.200.025.455 – choriocarcinoma
• MeSH  C04.557.470.200.025.455.750 – choriocarcinoma, non-gestational
• MeSH  C04.557.470.200.025.455.875 – trophoblastic tumor, placental site
• MeSH  C04.557.470.200.025.480 – cystadenocarcinoma
• MeSH  C04.557.470.200.025.480.225 – cystadenocarcinoma, mucinous
• MeSH  C04.557.470.200.025.480.230 – cystadenocarcinoma, papillary
• MeSH  C04.557.470.200.025.480.240 – cystadenocarcinoma, serous
• MeSH  C04.557.470.200.025.540 – klatskin's tumor
• MeSH  C04.557.470.200.025.660 – paget's disease, extramammary
• MeSH  C04.557.470.200.025.715 – pulmonary adenomatosis, ovine
• MeSH  C04.557.470.200.150 – carcinoma, adenosquamous
• MeSH  C04.557.470.200.165 – carcinoma, basal cell
• MeSH  C04.557.470.200.165.150 – basal cell nevus syndrome
• MeSH  C04.557.470.200.170 – carcinoma, basosquamous
• MeSH  C04.557.470.200.200 – carcinoma, ehrlich tumor
• MeSH  C04.557.470.200.220 – carcinoma, giant cell
• MeSH  C04.557.470.200.240 – carcinoma in situ
• MeSH  C04.557.470.200.240.250 – cervical intraepithelial neoplasia
• MeSH  C04.557.470.200.240.500 – prostatic intraepithelial neoplasia
• MeSH  C04.557.470.200.255 – carcinoma, krebs 2
• MeSH  C04.557.470.200.260 – carcinoma, large cell
• MeSH  C04.557.470.200.280 – carcinoma, lewis lung
• MeSH  C04.557.470.200.300 – carcinoma, non-small-cell lung
• MeSH  C04.557.470.200.360 – carcinoma, papillary
• MeSH  C04.557.470.200.400 – carcinoma, squamous cell
• MeSH  C04.557.470.200.400.130 – bowen's disease
• MeSH  C04.557.470.200.430 – carcinoma, transitional cell
• MeSH  C04.557.470.200.450 – carcinoma, verrucous
• MeSH  C04.557.470.550 – neoplasms, adnexal and skin appendage
• MeSH  C04.557.470.550.105 – adenocarcinoma, sebaceous
• MeSH  C04.557.470.550.175 – adenoma, sweat gland
• MeSH  C04.557.470.550.175.125 – acrospiroma, eccrine
• MeSH  C04.557.470.550.175.375 – hidrocystoma
• MeSH  C04.557.470.550.175.800 – syringoma
• MeSH  C04.557.470.550.420 – carcinoma, skin appendage
• MeSH  C04.557.470.565 – neoplasms, basal cell
• MeSH  C04.557.470.565.165 – carcinoma, basal cell
• MeSH  C04.557.470.565.165.150 – basal cell nevus syndrome
• MeSH  C04.557.470.565.170 – carcinoma, basosquamous
• MeSH  C04.557.470.565.625 – pilomatrixoma
• MeSH  C04.557.470.590 – neoplasms, cystic, mucinous, and serous
• MeSH  C04.557.470.590.075 – adenocarcinoma, mucinous
• MeSH  C04.557.470.590.340 – carcinoma, mucoepidermoid
• MeSH  C04.557.470.590.415 – carcinoma, signet ring cell
• MeSH  C04.557.470.590.415.410 – krukenberg tumor
• MeSH  C04.557.470.590.480 – cystadenocarcinoma
• MeSH  C04.557.470.590.480.225 – cystadenocarcinoma, mucinous
• MeSH  C04.557.470.590.480.230 – cystadenocarcinoma, papillary
• MeSH  C04.557.470.590.480.240 – cystadenocarcinoma, serous
• MeSH  C04.557.470.590.485 – cystadenoma
• MeSH  C04.557.470.590.485.225 – cystadenoma, mucinous
• MeSH  C04.557.470.590.485.230 – cystadenoma, papillary
• MeSH  C04.557.470.590.485.240 – cystadenoma, serous
• MeSH  C04.557.470.590.580 – mucoepidermoid tumor
• MeSH  C04.557.470.590.782 – pseudomyxoma peritonei
• MeSH  C04.557.470.615 – neoplasms, ductal, lobular, and medullary
• MeSH  C04.557.470.615.132 – carcinoma, ductal
• MeSH  C04.557.470.615.132.500 – carcinoma, ductal, breast
• MeSH  C04.557.470.615.132.750 – carcinoma, pancreatic ductal
• MeSH  C04.557.470.615.275 – carcinoma, intraductal, noninfiltrating
• MeSH  C04.557.470.615.275.625 – paget's disease, mammary
• MeSH  C04.557.470.615.305 – carcinoma, lobular
• MeSH  C04.557.470.615.315 – carcinoma, medullary
• MeSH  C04.557.470.615.660 – paget's disease, extramammary
• MeSH  C04.557.470.615.670 – papilloma, intraductal
• MeSH  C04.557.470.625 – neoplasms, fibroepithelial
• MeSH  C04.557.470.625.050 – adenofibroma
• MeSH  C04.557.470.625.150 – brenner tumor
• MeSH  C04.557.470.625.350 – fibroadenoma
• MeSH  C04.557.470.660 – neoplasms, mesothelial
• MeSH  C04.557.470.660.200 – adenomatoid tumor
• MeSH  C04.557.470.660.510 – mesothelioma
• MeSH  C04.557.470.660.510.515 – mesothelioma, cystic
• MeSH  C04.557.470.670 – neoplasms, neuroepithelial
• MeSH  C04.557.470.670.355 – ganglioneuroma
• MeSH  C04.557.470.670.380 – glioma
• MeSH  C04.557.470.670.380.080 – astrocytoma
• MeSH  C04.557.470.670.380.080.335 – glioblastoma
• MeSH  C04.557.470.670.380.080.667 – optic nerve glioma
• MeSH  C04.557.470.670.380.290 – ependymoma
• MeSH  C04.557.470.670.380.290.390 – glioma, subependymal
• MeSH  C04.557.470.670.380.350 – ganglioglioma
• MeSH  C04.557.470.670.380.400 – gliosarcoma
• MeSH  C04.557.470.670.380.515 – medulloblastoma
• MeSH  C04.557.470.670.380.590 – oligodendroglioma
• MeSH  C04.557.470.670.380.795 – optic nerve glioma
• MeSH  C04.557.470.670.580 – neurocytoma
• MeSH  C04.557.470.670.590 – neuroectodermal tumors, primitive
• MeSH  C04.557.470.670.590.500 – medulloblastoma
• MeSH  C04.557.470.670.590.650 – neuroectodermal tumors, primitive, peripheral
• MeSH  C04.557.470.670.590.650.550 – neuroblastoma
• MeSH  C04.557.470.670.590.650.550.150 – esthesioneuroblastoma, olfactory
• MeSH  C04.557.470.670.590.650.550.300 – ganglioneuroblastoma
• MeSH  C04.557.470.670.657 – pinealoma
• MeSH  C04.557.470.670.725 – retinoblastoma
• MeSH  C04.557.470.700 – neoplasms, squamous cell
• MeSH  C04.557.470.700.040 – acanthoma
• MeSH  C04.557.470.700.360 – carcinoma, papillary
• MeSH  C04.557.470.700.400 – carcinoma, squamous cell
• MeSH  C04.557.470.700.400.130 – bowen's disease
• MeSH  C04.557.470.700.450 – carcinoma, verrucous
• MeSH  C04.557.470.700.600 – papilloma
• MeSH  C04.557.470.700.600.610 – papilloma, inverted

MeSH  C04.557.475 – neoplasms, gonadal tissue

• MeSH  C04.557.475.395 – gonadoblastoma
• MeSH  C04.557.475.750 – sex cord-gonadal stromal tumors
• MeSH  C04.557.475.750.656 – granulosa cell tumor
• MeSH  C04.557.475.750.751 – luteoma
• MeSH  C04.557.475.750.847 – sertoli-leydig cell tumor
• MeSH  C04.557.475.750.847.249 – leydig cell tumor
• MeSH  C04.557.475.750.847.500 – sertoli cell tumor
• MeSH  C04.557.475.750.875 – thecoma

MeSH  C04.557.580 – neoplasms, nerve tissue

• MeSH  C04.557.580.520 – meningioma
• MeSH  C04.557.580.600 – nerve sheath neoplasms
• MeSH  C04.557.580.600.290 – neurilemmoma
• MeSH  C04.557.580.600.580 – neurofibroma
• MeSH  C04.557.580.600.580.585 – neurofibroma, plexiform
• MeSH  C04.557.580.600.580.590 – neurofibromatosis
• MeSH  C04.557.580.600.580.590.650 – neurofibromatosis 1
• MeSH  C04.557.580.600.580.590.655 – neurofibromatosis 2
• MeSH  C04.557.580.600.580.795 – neurofibrosarcoma
• MeSH  C04.557.580.600.590 – neurofibrosarcoma
• MeSH  C04.557.580.600.610 – neuroma
• MeSH  C04.557.580.600.610.595 – neurilemmoma
• MeSH  C04.557.580.600.610.595.610 – neuroma, acoustic
• MeSH  C04.557.580.600.610.595.610.500 – neurofibromatosis 2
• MeSH  C04.557.580.600.625 – neurothekeoma
• MeSH  C04.557.580.625 – neuroectodermal tumors
• MeSH  C04.557.580.625.200 – craniopharyngioma
• MeSH  C04.557.580.625.600 – neoplasms, neuroepithelial
• MeSH  C04.557.580.625.600.355 – ganglioneuroma
• MeSH  C04.557.580.625.600.380 – glioma
• MeSH  C04.557.580.625.600.380.080 – astrocytoma
• MeSH  C04.557.580.625.600.380.080.335 – glioblastoma
• MeSH  C04.557.580.625.600.380.080.667 – optic nerve glioma
• MeSH  C04.557.580.625.600.380.290 – ependymoma
• MeSH  C04.557.580.625.600.380.290.390 – glioma, subependymal
• MeSH  C04.557.580.625.600.380.350 – ganglioglioma
• MeSH  C04.557.580.625.600.380.400 – gliosarcoma
• MeSH  C04.557.580.625.600.380.515 – medulloblastoma
• MeSH  C04.557.580.625.600.380.590 – oligodendroglioma
• MeSH  C04.557.580.625.600.380.795 – optic nerve glioma
• MeSH  C04.557.580.625.600.580 – neurocytoma
• MeSH  C04.557.580.625.600.590 – neuroectodermal tumors, primitive
• MeSH  C04.557.580.625.600.590.500 – medulloblastoma
• MeSH  C04.557.580.625.600.590.650 – neuroectodermal tumors, primitive, peripheral
• MeSH  C04.557.580.625.600.590.650.550 – neuroblastoma
• MeSH  C04.557.580.625.600.590.650.550.150 – esthesioneuroblastoma, olfactory
• MeSH  C04.557.580.625.600.590.650.550.300 – ganglioneuroblastoma
• MeSH  C04.557.580.625.600.657 – pinealoma
• MeSH  C04.557.580.625.600.725 – retinoblastoma
• MeSH  C04.557.580.625.630 – neuroectodermal tumor, melanotic
• MeSH  C04.557.580.625.650 – neuroendocrine tumors
• MeSH  C04.557.580.625.650.025 – adenoma, acidophil
• MeSH  C04.557.580.625.650.075 – adenoma, basophil
• MeSH  C04.557.580.625.650.095 – adenoma, chromophobe
• MeSH  C04.557.580.625.650.135 – apudoma
• MeSH  C04.557.580.625.650.200 – carcinoid tumor
• MeSH  C04.557.580.625.650.200.500 – malignant carcinoid syndrome
• MeSH  C04.557.580.625.650.200.500.205 – carcinoid heart disease
• MeSH  C04.557.580.625.650.240 – carcinoma, neuroendocrine
• MeSH  C04.557.580.625.650.240.315 – carcinoma, medullary
• MeSH  C04.557.580.625.650.240.325 – carcinoma, merkel cell
• MeSH  C04.557.580.625.650.240.390 – carcinoma, small cell
• MeSH  C04.557.580.625.650.510 – melanoma
• MeSH  C04.557.580.625.650.510.385 – hutchinson's melanotic freckle
• MeSH  C04.557.580.625.650.510.515 – melanoma, amelanotic
• MeSH  C04.557.580.625.650.510.525 – melanoma, experimental
• MeSH  C04.557.580.625.650.595 – neurilemmoma
• MeSH  C04.557.580.625.650.595.610 – neuroma, acoustic
• MeSH  C04.557.580.625.650.700 – paraganglioma
• MeSH  C04.557.580.625.650.700.705 – paraganglioma, extra-adrenal
• MeSH  C04.557.580.625.650.700.705.220 – carotid body tumor
• MeSH  C04.557.580.625.650.700.705.340 – glomus jugulare tumor
• MeSH  C04.557.580.625.650.700.705.360 – glomus tympanicum tumor
• MeSH  C04.557.580.625.650.700.725 – pheochromocytoma

MeSH  C04.557.645 – neoplasms, vascular tissue

• MeSH  C04.557.645.100 – angiofibroma
• MeSH  C04.557.645.115 – angiokeratoma
• MeSH  C04.557.645.350 – glomus tumor
• MeSH  C04.557.645.375 – hemangioma
• MeSH  C04.557.645.375.185 – central nervous system venous angioma
• MeSH  C04.557.645.375.370 – hemangioendothelioma
• MeSH  C04.557.645.375.370.380 – hemangioendothelioma, epithelioid
• MeSH  C04.557.645.375.380 – hemangioma, capillary
• MeSH  C04.557.645.375.380.370 – hemangioblastoma
• MeSH  C04.557.645.375.385 – hemangioma, cavernous
• MeSH  C04.557.645.375.385.500 – hemangioma, cavernous, central nervous system
• MeSH  C04.557.645.375.850 – sturge-weber syndrome
• MeSH  C04.557.645.380 – hemangiopericytoma
• MeSH  C04.557.645.390 – hemangiosarcoma
• MeSH  C04.557.645.520 – meningioma
• MeSH  C04.557.645.750 – sarcoma, kaposi

MeSH  C04.557.665 – nevi and melanomas

• MeSH  C04.557.665.510 – melanoma
• MeSH  C04.557.665.510.385 – hutchinson's melanotic freckle
• MeSH  C04.557.665.510.515 – melanoma, amelanotic
• MeSH  C04.557.665.510.525 – melanoma, experimental
• MeSH  C04.557.665.560 – nevus
• MeSH  C04.557.665.560.260 – dysplastic nevus syndrome
• MeSH  C04.557.665.560.590 – nevus, intradermal
• MeSH  C04.557.665.560.615 – nevus, pigmented
• MeSH  C04.557.665.560.615.530 – mongolian spot
• MeSH  C04.557.665.560.615.550 – nevus, blue
• MeSH  C04.557.665.560.615.585 – nevus of ota
• MeSH  C04.557.665.560.615.625 – nevus, spindle cell
• MeSH  C04.557.665.560.615.625.585 – nevus, epithelioid and spindle cell

MeSH  C04.557.695 – odontogenic tumors

• MeSH  C04.557.695.065 – ameloblastoma
• MeSH  C04.557.695.210 – cementoma
• MeSH  C04.557.695.605 – odontogenic cyst, calcifying
• MeSH  C04.557.695.607 – odontogenic tumor, squamous
• MeSH  C04.557.695.610 – odontoma

MeSH  C04.588 – neoplasms by site

MeSH  C04.588.033 – abdominal neoplasms

• MeSH  C04.588.033.513 – peritoneal neoplasms
• MeSH  C04.588.033.731 – retroperitoneal neoplasms

MeSH  C04.588.083 – anal gland neoplasms

MeSH  C04.588.149 – bone neoplasms

• MeSH  C04.588.149.030 – adamantinoma
• MeSH  C04.588.149.276 – femoral neoplasms
• MeSH  C04.588.149.721 – skull neoplasms
• MeSH  C04.588.149.721.450 – jaw neoplasms
• MeSH  C04.588.149.721.450.583 – mandibular neoplasms
• MeSH  C04.588.149.721.450.601 – maxillary neoplasms
• MeSH  C04.588.149.721.450.692 – palatal neoplasms
• MeSH  C04.588.149.721.600 – nose neoplasms
• MeSH  C04.588.149.721.656 – orbital neoplasms
• MeSH  C04.588.149.721.828 – skull base neoplasms
• MeSH  C04.588.149.828 – spinal neoplasms

MeSH  C04.588.180 – breast neoplasms

• MeSH  C04.588.180.260 – breast neoplasms, male
• MeSH  C04.588.180.390 – carcinoma, ductal, breast
• MeSH  C04.588.180.762 – phyllodes tumor

MeSH  C04.588.274 – digestive system neoplasms

• MeSH  C04.588.274.120 – biliary tract neoplasms
• MeSH  C04.588.274.120.250 – bile duct neoplasms
• MeSH  C04.588.274.120.250.250 – common bile duct neoplasms
• MeSH  C04.588.274.120.401 – gallbladder neoplasms
• MeSH  C04.588.274.476 – gastrointestinal neoplasms
• MeSH  C04.588.274.476.205 – esophageal neoplasms
• MeSH  C04.588.274.476.308 – gastrointestinal stromal tumors
• MeSH  C04.588.274.476.411 – intestinal neoplasms
• MeSH  C04.588.274.476.411.184 – cecal neoplasms
• MeSH  C04.588.274.476.411.184.290 – appendiceal neoplasms
• MeSH  C04.588.274.476.411.307 – colorectal neoplasms
• MeSH  C04.588.274.476.411.307.089 – adenomatous polyposis coli
• MeSH  C04.588.274.476.411.307.089.393 – gardner syndrome
• MeSH  C04.588.274.476.411.307.180 – colonic neoplasms
• MeSH  C04.588.274.476.411.307.180.089 – adenomatous polyposis coli
• MeSH  C04.588.274.476.411.307.180.089.500 – gardner syndrome
• MeSH  C04.588.274.476.411.307.180.800 – sigmoid neoplasms
• MeSH  C04.588.274.476.411.307.190 – colorectal neoplasms, hereditary nonpolyposis
• MeSH  C04.588.274.476.411.307.790 – rectal neoplasms
• MeSH  C04.588.274.476.411.307.790.040 – anus neoplasms
• MeSH  C04.588.274.476.411.307.790.040.040 – anal gland neoplasms
• MeSH  C04.588.274.476.411.445 – duodenal neoplasms
• MeSH  C04.588.274.476.411.501 – ileal neoplasms
• MeSH  C04.588.274.476.411.523 – jejunal neoplasms
• MeSH  C04.588.274.476.767 – stomach neoplasms
• MeSH  C04.588.274.623 – liver neoplasms
• MeSH  C04.588.274.623.040 – adenoma, liver cell
• MeSH  C04.588.274.623.160 – carcinoma, hepatocellular
• MeSH  C04.588.274.623.460 – liver neoplasms, experimental
• MeSH  C04.588.274.761 – pancreatic neoplasms
• MeSH  C04.588.274.761.249 – adenoma, islet cell
• MeSH  C04.588.274.761.249.500 – insulinoma
• MeSH  C04.588.274.761.500 – carcinoma, islet cell
• MeSH  C04.588.274.761.500.124 – gastrinoma
• MeSH  C04.588.274.761.500.249 – glucagonoma
• MeSH  C04.588.274.761.500.500 – somatostatinoma
• MeSH  C04.588.274.761.500.750 – vipoma
• MeSH  C04.588.274.761.750 – carcinoma, pancreatic ductal
• MeSH  C04.588.274.780 – peritoneal neoplasms

MeSH  C04.588.322 – endocrine gland neoplasms

• MeSH  C04.588.322.078 – adrenal gland neoplasms
• MeSH  C04.588.322.078.265 – adrenal cortex neoplasms
• MeSH  C04.588.322.078.265.500 – adrenocortical adenoma
• MeSH  C04.588.322.078.265.750 – adrenocortical carcinoma
• MeSH  C04.588.322.400 – multiple endocrine neoplasia
• MeSH  C04.588.322.400.500 – multiple endocrine neoplasia type 1
• MeSH  C04.588.322.400.505 – multiple endocrine neoplasia type 2a
• MeSH  C04.588.322.400.510 – multiple endocrine neoplasia type 2b
• MeSH  C04.588.322.421 – pancreatic neoplasms
• MeSH  C04.588.322.421.249 – adenoma, islet cell
• MeSH  C04.588.322.421.249.500 – insulinoma
• MeSH  C04.588.322.421.500 – carcinoma, islet cell
• MeSH  C04.588.322.421.500.124 – gastrinoma
• MeSH  C04.588.322.421.500.249 – glucagonoma
• MeSH  C04.588.322.421.500.500 – somatostatinoma
• MeSH  C04.588.322.421.500.750 – vipoma
• MeSH  C04.588.322.421.750 – carcinoma, pancreatic ductal
• MeSH  C04.588.322.455 – ovarian neoplasms
• MeSH  C04.588.322.455.398 – granulosa cell tumor
• MeSH  C04.588.322.455.464 – luteoma
• MeSH  C04.588.322.455.531 – meigs syndrome
• MeSH  C04.588.322.455.648 – sertoli-leydig cell tumor
• MeSH  C04.588.322.455.765 – thecoma
• MeSH  C04.588.322.490 – paraneoplastic endocrine syndromes
• MeSH  C04.588.322.525 – parathyroid neoplasms
• MeSH  C04.588.322.609 – pituitary neoplasms
• MeSH  C04.588.322.609.145 – acth-secreting pituitary adenoma
• MeSH  C04.588.322.609.145.500 – nelson syndrome
• MeSH  C04.588.322.609.292 – growth hormone-secreting pituitary adenoma
• MeSH  C04.588.322.609.792 – prolactinoma
• MeSH  C04.588.322.762 – testicular neoplasms
• MeSH  C04.588.322.762.500 – sertoli-leydig cell tumor
• MeSH  C04.588.322.894 – thyroid neoplasms
• MeSH  C04.588.322.894.800 – thyroid nodule

MeSH  C04.588.364 – eye neoplasms

• MeSH  C04.588.364.235 – conjunctival neoplasms
• MeSH  C04.588.364.659 – orbital neoplasms
• MeSH  C04.588.364.818 – retinal neoplasms
• MeSH  C04.588.364.818.760 – retinoblastoma
• MeSH  C04.588.364.978 – uveal neoplasms
• MeSH  C04.588.364.978.223 – choroid neoplasms
• MeSH  C04.588.364.978.400 – iris neoplasms

MeSH  C04.588.443 – head and neck neoplasms

• MeSH  C04.588.443.353 – esophageal neoplasms
• MeSH  C04.588.443.392 – facial neoplasms
• MeSH  C04.588.443.392.500 – eyelid neoplasms
• MeSH  C04.588.443.591 – mouth neoplasms
• MeSH  C04.588.443.591.402 – gingival neoplasms
• MeSH  C04.588.443.591.545 – leukoplakia, oral
• MeSH  C04.588.443.591.545.500 – leukoplakia, hairy
• MeSH  C04.588.443.591.550 – lip neoplasms
• MeSH  C04.588.443.591.692 – palatal neoplasms
• MeSH  C04.588.443.591.824 – salivary gland neoplasms
• MeSH  C04.588.443.591.824.695 – parotid neoplasms
• MeSH  C04.588.443.591.824.882 – sublingual gland neoplasms
• MeSH  C04.588.443.591.824.885 – submandibular gland neoplasms
• MeSH  C04.588.443.591.925 – tongue neoplasms
• MeSH  C04.588.443.665 – otorhinolaryngologic neoplasms
• MeSH  C04.588.443.665.312 – ear neoplasms
• MeSH  C04.588.443.665.481 – laryngeal neoplasms
• MeSH  C04.588.443.665.650 – nose neoplasms
• MeSH  C04.588.443.665.650.693 – paranasal sinus neoplasms
• MeSH  C04.588.443.665.650.693.575 – maxillary sinus neoplasms
• MeSH  C04.588.443.665.710 – pharyngeal neoplasms
• MeSH  C04.588.443.665.710.485 – hypopharyngeal neoplasms
• MeSH  C04.588.443.665.710.650 – nasopharyngeal neoplasms
• MeSH  C04.588.443.665.710.684 – oropharyngeal neoplasms
• MeSH  C04.588.443.665.710.684.800 – tonsillar neoplasms
• MeSH  C04.588.443.680 – parathyroid neoplasms
• MeSH  C04.588.443.915 – thyroid neoplasms
• MeSH  C04.588.443.915.800 – thyroid nodule
• MeSH  C04.588.443.925 – tracheal neoplasms

MeSH  C04.588.448 – hematologic neoplasms

• MeSH  C04.588.448.200 – bone marrow neoplasms

MeSH  C04.588.531 – mammary neoplasms, animal

• MeSH  C04.588.531.500 – mammary neoplasms, experimental

MeSH  C04.588.614 – nervous system neoplasms

• MeSH  C04.588.614.250 – central nervous system neoplasms
• MeSH  C04.588.614.250.195 – brain neoplasms
• MeSH  C04.588.614.250.195.205 – cerebral ventricle neoplasms
• MeSH  C04.588.614.250.195.205.200 – choroid plexus neoplasms
• MeSH  C04.588.614.250.195.205.200.500 – papilloma, choroid plexus
• MeSH  C04.588.614.250.195.411 – infratentorial neoplasms
• MeSH  C04.588.614.250.195.411.100 – brain stem neoplasms
• MeSH  C04.588.614.250.195.411.211 – cerebellar neoplasms
• MeSH  C04.588.614.250.195.648 – neurocytoma
• MeSH  C04.588.614.250.195.766 – pinealoma
• MeSH  C04.588.614.250.195.885 – supratentorial neoplasms
• MeSH  C04.588.614.250.195.885.500 – hypothalamic neoplasms
• MeSH  C04.588.614.250.195.885.500.600 – pituitary neoplasms
• MeSH  C04.588.614.250.387 – central nervous system cysts
• MeSH  C04.588.614.250.387.100 – arachnoid cysts
• MeSH  C04.588.614.250.580 – meningeal neoplasms
• MeSH  C04.588.614.250.580.500 – meningioma
• MeSH  C04.588.614.250.803 – spinal cord neoplasms
• MeSH  C04.588.614.250.803.342 – epidural neoplasms
• MeSH  C04.588.614.300 – cranial nerve neoplasms
• MeSH  C04.588.614.300.600 – optic nerve neoplasms
• MeSH  C04.588.614.300.600.600 – optic nerve glioma
• MeSH  C04.588.614.525 – neuroma, acoustic
• MeSH  C04.588.614.525.500 – neurofibromatosis 2
• MeSH  C04.588.614.550 – paraneoplastic syndromes, nervous system
• MeSH  C04.588.614.550.225 – lambert-eaton myasthenic syndrome
• MeSH  C04.588.614.550.450 – limbic encephalitis
• MeSH  C04.588.614.550.550 – myelitis, transverse
• MeSH  C04.588.614.550.650 – paraneoplastic cerebellar degeneration
• MeSH  C04.588.614.550.700 – paraneoplastic polyneuropathy
• MeSH  C04.588.614.596 – peripheral nervous system neoplasms
• MeSH  C04.588.614.596.240 – cranial nerve neoplasms
• MeSH  C04.588.614.596.240.015 – neuroma, acoustic
• MeSH  C04.588.614.596.240.240 – optic nerve neoplasms
• MeSH  C04.588.614.596.240.240.500 – optic nerve glioma

MeSH  C04.588.699 – pelvic neoplasms

MeSH  C04.588.805 – skin neoplasms

• MeSH  C04.588.805.040 – acanthoma
• MeSH  C04.588.805.578 – sebaceous gland neoplasms
• MeSH  C04.588.805.776 – sweat gland neoplasms

MeSH  C04.588.839 – soft tissue neoplasms

• MeSH  C04.588.839.500 – muscle neoplasms
• MeSH  C04.588.839.750 – vascular neoplasms

MeSH  C04.588.842 – splenic neoplasms

MeSH  C04.588.894 – thoracic neoplasms

• MeSH  C04.588.894.309 – heart neoplasms
• MeSH  C04.588.894.479 – mediastinal neoplasms
• MeSH  C04.588.894.797 – respiratory tract neoplasms
• MeSH  C04.588.894.797.265 – bronchial neoplasms
• MeSH  C04.588.894.797.520 – lung neoplasms
• MeSH  C04.588.894.797.520.220 – carcinoma, bronchogenic
• MeSH  C04.588.894.797.520.230 – carcinoma, non-small-cell lung
• MeSH  C04.588.894.797.520.235 – carcinoma, small cell
• MeSH  C04.588.894.797.520.240 – coin lesion, pulmonary
• MeSH  C04.588.894.797.520.734 – pancoast's syndrome
• MeSH  C04.588.894.797.520.867 – pulmonary blastoma
• MeSH  C04.588.894.797.520.933 – pulmonary sclerosing hemangioma
• MeSH  C04.588.894.797.640 – pleural neoplasms
• MeSH  C04.588.894.797.640.700 – pleural effusion, malignant
• MeSH  C04.588.894.797.760 – tracheal neoplasms
• MeSH  C04.588.894.949 – thymus neoplasms
• MeSH  C04.588.894.949.500 – thymoma

MeSH  C04.588.945 – urogenital neoplasms

• MeSH  C04.588.945.418 – genital neoplasms, female
• MeSH  C04.588.945.418.365 – fallopian tube neoplasms
• MeSH  C04.588.945.418.948 – uterine neoplasms
• MeSH  C04.588.945.418.948.585 – endometrial neoplasms
• MeSH  C04.588.945.418.948.585.124 – carcinoma, endometrioid
• MeSH  C04.588.945.418.948.585.374 – endometrial stromal tumors
• MeSH  C04.588.945.418.948.585.374.500 – sarcoma, endometrial stromal
• MeSH  C04.588.945.418.948.850 – uterine cervical neoplasms
• MeSH  C04.588.945.418.955 – vaginal neoplasms
• MeSH  C04.588.945.418.968 – vulvar neoplasms
• MeSH  C04.588.945.440 – genital neoplasms, male
• MeSH  C04.588.945.440.715 – penile neoplasms
• MeSH  C04.588.945.440.770 – prostatic neoplasms
• MeSH  C04.588.945.440.915 – testicular neoplasms
• MeSH  C04.588.945.947 – urologic neoplasms
• MeSH  C04.588.945.947.125 – bladder neoplasms
• MeSH  C04.588.945.947.535 – kidney neoplasms
• MeSH  C04.588.945.947.535.160 – carcinoma, renal cell
• MeSH  C04.588.945.947.535.585 – wilms tumor
• MeSH  C04.588.945.947.535.585.220 – denys-drash syndrome
• MeSH  C04.588.945.947.535.585.950 – wagr syndrome
• MeSH  C04.588.945.947.535.790 – nephroma, mesoblastic
• MeSH  C04.588.945.947.940 – ureteral neoplasms
• MeSH  C04.588.945.947.945 – urethral neoplasms
• MeSH  C04.588.945.956 – venereal tumors, veterinary

MeSH  C04.619 – neoplasms, experimental

MeSH  C04.619.045 – carcinoma 256, walker

MeSH  C04.619.124 – carcinoma, brown-pearce

MeSH  C04.619.169 – carcinoma, ehrlich tumor

MeSH  C04.619.214 – carcinoma, krebs 2

MeSH  C04.619.230 – carcinoma, lewis lung

MeSH  C04.619.531 – leukemia, experimental

• MeSH  C04.619.531.216 – avian leukosis
• MeSH  C04.619.531.594 – leukemia L1210
• MeSH  C04.619.531.602 – leukemia L5178
• MeSH  C04.619.531.782 – leukemia p388

MeSH  C04.619.540 – liver neoplasms, experimental

MeSH  C04.619.590 – mammary neoplasms, experimental

MeSH  C04.619.600 – melanoma, experimental

MeSH  C04.619.857 – sarcoma, experimental

• MeSH  C04.619.857.573 – sarcoma 37
• MeSH  C04.619.857.656 – sarcoma 180
• MeSH  C04.619.857.800 – sarcoma, avian
• MeSH  C04.619.857.822 – sarcoma, yoshida

MeSH  C04.619.935 – tumor virus infections

• MeSH  C04.619.935.120 – avian leukosis
• MeSH  C04.619.935.313 – epstein-barr virus infections
• MeSH  C04.619.935.313.165 – burkitt lymphoma
• MeSH  C04.619.935.489 – marek disease
• MeSH  C04.619.935.800 – sarcoma, avian

MeSH  C04.626 – neoplasms, hormone-dependent

MeSH  C04.651 – neoplasms, multiple primary

MeSH  C04.651.435 – hamartoma syndrome, multiple

MeSH  C04.651.550 – lipomatosis, multiple symmetrical

MeSH  C04.651.600 – multiple endocrine neoplasia

• MeSH  C04.651.600.500 – multiple endocrine neoplasia type 1
• MeSH  C04.651.600.505 – multiple endocrine neoplasia type 2a
• MeSH  C04.651.600.510 – multiple endocrine neoplasia type 2b

MeSH  C04.651.750 – proteus syndrome

MeSH  C04.666 – neoplasms, post-traumatic

MeSH  C04.682 – neoplasms, radiation-induced

MeSH  C04.682.512 – leukemia, radiation-induced

MeSH  C04.692 – neoplasms, second primary

MeSH  C04.697 – neoplastic processes

MeSH  C04.697.045 – anaplasia

MeSH  C04.697.152 – cell transformation, neoplastic

• MeSH  C04.697.152.110 – blast crisis
• MeSH  C04.697.152.160 – cell transformation, viral

MeSH  C04.697.160 – cocarcinogenesis

MeSH  C04.697.645 – neoplasm invasiveness

• MeSH  C04.697.645.500 – leukemic infiltration

MeSH  C04.697.650 – neoplasm metastasis

• MeSH  C04.697.650.560 – lymphatic metastasis
• MeSH  C04.697.650.645 – neoplasm circulating cells
• MeSH  C04.697.650.830 – neoplasm seeding
• MeSH  C04.697.650.895 – neoplasms, unknown primary

MeSH  C04.697.655 – neoplasm recurrence, local

MeSH  C04.697.670 – neoplasm regression, spontaneous

MeSH  C04.697.700 – neoplasm, residual

MeSH  C04.700 – neoplastic syndromes, hereditary

MeSH  C04.700.100 – adenomatous polyposis coli

• MeSH  C04.700.100.392 – gardner syndrome

MeSH  C04.700.175 – basal cell nevus syndrome

MeSH  C04.700.250 – colorectal neoplasms, hereditary nonpolyposis

MeSH  C04.700.305 – dysplastic nevus syndrome

MeSH  C04.700.330 – exostoses, multiple hereditary

MeSH  C04.700.435 – hamartoma syndrome, multiple

MeSH  C04.700.600 – li-fraumeni syndrome

MeSH  C04.700.630 – multiple endocrine neoplasia

• MeSH  C04.700.630.500 – multiple endocrine neoplasia type 1
• MeSH  C04.700.630.505 – multiple endocrine neoplasia type 2a
• MeSH  C04.700.630.510 – multiple endocrine neoplasia type 2b

MeSH  C04.700.635 – wilms tumor

• MeSH  C04.700.635.220 – denys-drash syndrome
• MeSH  C04.700.635.950 – wagr syndrome

MeSH  C04.700.645 – neurofibromatosis

• MeSH  C04.700.645.650 – neurofibromatosis 1
• MeSH  C04.700.645.655 – neurofibromatosis 2

MeSH  C04.700.705 – peutz-jeghers syndrome

MeSH  C04.700.852 – sturge-weber syndrome

MeSH  C04.730 – paraneoplastic syndromes

MeSH  C04.730.713 – paraneoplastic endocrine syndromes

• MeSH  C04.730.713.317 – acth syndrome, ectopic
• MeSH  C04.730.713.988 – zollinger-ellison syndrome

MeSH  C04.730.856 – paraneoplastic syndromes, nervous system

• MeSH  C04.730.856.225 – lambert-eaton myasthenic syndrome
• MeSH  C04.730.856.437 – limbic encephalitis
• MeSH  C04.730.856.543 – myelitis, transverse
• MeSH  C04.730.856.650 – paraneoplastic cerebellar degeneration
• MeSH  C04.730.856.700 – paraneoplastic polyneuropathy

MeSH  C04.834 – precancerous conditions

MeSH  C04.834.288 – erythroplasia

MeSH  C04.834.512 – leukoplakia

• MeSH  C04.834.512.513 – leukoplakia, oral
• MeSH  C04.834.512.513.500 – leukoplakia, hairy

MeSH  C04.834.567 – lymphomatoid granulomatosis

MeSH  C04.834.580 – lymphomatoid papulosis

MeSH  C04.834.770 – preleukemia

MeSH  C04.834.818 – uterine cervical dysplasia

MeSH  C04.834.867 – xeroderma pigmentosum

MeSH  C04.850 – pregnancy complications, neoplastic

MeSH  C04.850.908 – trophoblastic neoplasms

• MeSH  C04.850.908.416 – gestational trophoblastic neoplasms
• MeSH  C04.850.908.416.186 – choriocarcinoma
• MeSH  C04.850.908.416.186.875 – trophoblastic tumor, placental site
• MeSH  C04.850.908.416.750 – hydatidiform mole
• MeSH  C04.850.908.416.750.500 – hydatidiform mole, invasive

MeSH  C04.925 – tumor virus infections

MeSH  C04.925.120 – avian leukosis

MeSH  C04.925.313 – epstein-barr virus infections

• MeSH  C04.925.313.165 – burkitt lymphoma

MeSH  C04.925.489 – marek disease

MeSH  C04.925.700 – sarcoma, avian

MeSH  C04.925.744 – warts

• MeSH  C04.925.744.500 – epidermodysplasia verruciformis

---

The list continues at List of MeSH codes (C05).